SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-065077
Filing Date
2022-10-20
Accepted
2022-10-20 08:00:19
Documents
13
Period of Report
2022-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea167333-8k_enzobiochem.htm   iXBRL 8-K 33736
2 PRESS RELEASE OF ENZO BIOCHEM, INC., DATED OCTOBER 20, 2022 ea167333ex99-1_enzobiochem.htm EX-99.1 9838
  Complete submission text file 0001213900-22-065077.txt   221206

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20221015.xsd EX-101.SCH 3242
4 XBRL LABEL FILE enz-20221015_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20221015_pre.xml EX-101.PRE 22370
7 EXTRACTED XBRL INSTANCE DOCUMENT ea167333-8k_enzobiochem_htm.xml XML 3673
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 221319774
SIC: 8071 Services-Medical Laboratories